Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiome and Immunosuppression: The Mission Study

NCT04953715 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT04953715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiome and Immunosuppression: The Mission Study
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Observational
Overall status
Active, not recruiting
Start date
February 12, 2020
Completion date
January 1, 2033
Enrollment
140 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant, kidney transplant rejection